Insider · CIK 0001682126
Sven Ante Lundberg
Files at MRUS (Merus N.V.), QTTB (Q32 Bio Inc.), VOR (Vor Biopharma Inc.). First filing -, latest -.
Sven Ante Lundberg files SEC Form 4 as CEO, president and director at MRUS (Merus N.V.), and also at QTTB (Q32 Bio Inc.), VOR (Vor Biopharma Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Sven Ante Lundberg has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 4, 2025 | VOR VOR BIOPHARMA INC. | 29,432 0.02% of outstanding | $62k | Aug 4, 2025 | none |
Transactions
Every row this insider has filed, 30 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,363 | $2.75 | $56k | 20,363 | Jan 30, 2026 |
| Dec 12, 2025 | MRUS Merus N.V. | UTender of shares Common Sharesindirect: Ante S Lundberg Qualified Annuity Interest Trust XI | -30,297 | $97.00 | $2.9M | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | UTender of shares Common Sharesindirect: Ante S Lundberg Qualified Annuity Int Trust X | -16,372 | $97.00 | $1.6M | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | UTender of shares Common Sharesindirect: Katrina Lundberg 2018 Irrevocable Trust | -9,191 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | UTender of shares Common Sharesindirect: Madeleine Lundberg 2018 Irrevocable Trust | -9,191 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | UTender of shares Common Sharesindirect: Kristian Ante Lundberg 2018 Irrevocable Trust | -9,192 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | UTender of shares Common Sharesindirect: Emily Lundberg 2018 Irrevocable Trust | -9,192 | $97.00 | $892k | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -312,620 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -351,628 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -300,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -360,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -380,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Dec 12, 2025 | MRUS Merus N.V. | DDisposition to issuer Share Option (right to buy)derivative | -295,000 | $0.00 | $0 | 0 | Dec 12, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Shares | -30,297 | $0.00 | $0 | 0 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Ante S Lundberg Qualified Annuity Interest Trust XI | +30,297 | $0.00 | $0 | 30,297 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Ante Sven Lundberg Qualified Annuity Interest Trust VI | -14,198 | $0.00 | $0 | 0 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Ante S Lundberg Qualified Annuity Int Trust VII | -12,215 | $0.00 | $0 | 0 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Ante Sven Lundberg Qualified Annuity Interest Trust VIII | -52,369 | $0.00 | $0 | 0 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Ante Sven Lundberg Qualified Annuity Interest Trust IX | -22,449 | $0.00 | $0 | 0 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Ante S Lundberg Qualified Annuity Int Trust X | -24,229 | $0.00 | $0 | 16,372 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Katrina Lundberg 2018 Irrevocable Trust | +2,538 | $0.00 | $0 | 9,191 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Madeleine Lundberg 2018 Irrevocable Trust | +2,539 | $0.00 | $0 | 9,191 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Kristian Ante Lundberg 2018 Irrevocable Trust | +2,539 | $0.00 | $0 | 9,192 | Nov 28, 2025 |
| Nov 25, 2025 | MRUS Merus N.V. | GGift Common Sharesindirect: Emily Lundberg 2018 Irrevocable Trust | +2,539 | $0.00 | $0 | 9,192 | Nov 28, 2025 |
| Oct 23, 2025 | QTTB Q32 Bio Inc. | AGrant or award Stock Option (Right to Buy)derivative | +53,521 | $0.00 | $0 | 53,521 | Oct 27, 2025 |
| May 22, 2025 | VOR Vor Biopharma Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | May 23, 2025 |
| Apr 17, 2025 | MRUS Merus N.V. | MOption exercise Common Shares | +3,797 | $12.54 | $48k | 3,797 | Apr 21, 2025 |
| Apr 17, 2025 | MRUS Merus N.V. | MOption exercise Common Shares | +26,500 | $13.52 | $358k | 30,297 | Apr 21, 2025 |
| Apr 17, 2025 | MRUS Merus N.V. | MOption exercise Share Option (right to buy)derivative | -3,797 | $12.54 | $48k | 0 | Apr 21, 2025 |
| Apr 17, 2025 | MRUS Merus N.V. | MOption exercise Share Option (right to buy)derivative | -26,500 | $13.52 | $358k | 312,620 | Apr 21, 2025 |
Questions about Sven Ante Lundberg
Answered from the filings on this page, as of the latest one.
Is Sven Ante Lundberg buying or selling?
Sven Ante Lundberg has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Sven Ante Lundberg's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sven Ante Lundberg has 0.
Where does Sven Ante Lundberg file Form 4?
Sven Ante Lundberg has filed Form 4 at MRUS (Merus N.V.) as President, CEO & PEO; QTTB (Q32 Bio Inc.); VOR (Vor Biopharma Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.